Enterra Medical
Tonka Bay, US · Founded 2021 · Delaware corporation
Enterra Medical makes Enterra Therapy, an implantable neurostimulation device that targets the chronic nausea and vomiting symptoms of gastroparesis caused by diabetes or unknown origin. It is intended for patients aged 18 to 70 whose symptoms are resistant to medication.
Founders & leadership
Board
TP
Timothy P HerbertChairman
Reported raises · per SEC filings
Form D private placements$19.4M disclosed across 1 round · 2022
▶$19.4MraisedFeb 2022 · 24 investors · Other Health CareRule 506(b)
▶$19.4MraisedFeb 2022 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Timothy P HerbertDirector
- Offering amount
- $19.4M
- Amount sold
- $19.4M
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Enterra Medical do?
- Enterra Medical makes Enterra Therapy, an implantable neurostimulation device that targets the chronic nausea and vomiting symptoms of gastroparesis caused by diabetes or unknown origin. It is intended for patients aged 18 to 70 whose symptoms are resistant to medication.
- How much funding has Enterra Medical raised?
- Enterra Medical has disclosed $19.4M raised across 1 round.
- Where is Enterra Medical headquartered?
- Enterra Medical is headquartered in Tonka Bay, US.